07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AMIO<br />

9247<br />

dehydratase (ALAD) activity is typically reduced by 80%, or more, from normal levels. ALAD activity<br />

can be inhibited in other situations including hereditary tyrosinemia type 1, lead intoxication, and<br />

exposure to styrene, trichloroethylene, and bromobenzene. These causes should be ruled out when<br />

considering a diagnosis of ADP.<br />

Reference Values:<br />

> or =4.0 nmol/L/sec<br />

3.5-3.9 nmol/L/sec (indeterminate)<br />

0.5 mcg/mL. Increased risk of<br />

toxicity is associated with amiodarone concentrations >2.5 mcg/mL. Although therapeutic and toxic<br />

ranges are based only on the parent drug, the active metabolite N-desethylamiodarone should be present<br />

in similar concentrations to amiodarone.<br />

Reference Values:<br />

AMIODARONE<br />

Therapeutic concentration: 0.5-2.0 mcg/mL<br />

Toxic concentration: >2.5 mcg/mL<br />

DESETHYLAMIODARONE<br />

No therapeutic range established; activity and serum concentration are similar to parent drug.<br />

Clinical References: 1. Goldschlager N, Epstein AE, Naccarelli GV, et al: A practical guide for<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 120

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!